U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938840) titled 'Opioid-Free Total Shoulder With Suzetrigine' on Nov. 10.

Brief Summary: This prospective, randomized, unblinded, controlled noninferiority study may benefit patients by determining whether an opioid-free postoperative analgesic pathway utilizing suzetrigine can provide adequate pain control following primary anatomic or reverse total shoulder arthroplasty compared with a standard opioid-containing pathway. If effective, this strategy may reduce or eliminate routine postoperative opioid use and associated adverse effects while maintaining patient satisfaction and adequate pain control. More broadly, this study will provide prospectiv...